Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin
about
Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 30 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@en
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@nl
type
label
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@en
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@nl
prefLabel
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@en
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@nl
P2093
P1476
Necroptosis inhibition as a th ...... 2-hydroxypropyl-β-cyclodextrin
@en
P2093
P304
P356
10.1016/J.YMGME.2018.10.009
P407
P577
2018-10-30T00:00:00Z